Clinical Gastroenterology and Hepatology
Volume 8, Issue 2 , Page 125, February 2010

Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes?

  • Robin Spiller

      Affiliations

    • Nottingham Digestive Diseases Centre Biomedical Research Unit, University Hospital, Nottingham, Nottinghamshire, United Kingdom
  • ,
  • Michael Camilleri

      Affiliations

    • Clinical Enteric Neuroscience, Translational and Epidemiological Research (CENTER), College of Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • George F. Longstreth

      Affiliations

    • Department of Gastroenterology, Kaiser Permanente Medical Care Plan, San Diego, California

Irritable bowel syndrome (IBS) is an extraordinarily prevalent condition, remaining one of the most common disorders gastroenterologists treat. Because there is no specific test for diagnosing IBS, experts have devised criteria to guide the clinician and researcher in making a diagnosis. Despite their widespread adoption, the Rome III criteria still engender debate regarding their utility and symptom-guided approach. Herein, 2 experts with divergent views explore this debate. A third expert concludes the article, outlining the strengths and weaknesses of each viewpoint.

 

PII: S1542-3565(09)01327-5

doi:10.1016/j.cgh.2009.12.018

Clinical Gastroenterology and Hepatology
Volume 8, Issue 2 , Page 125, February 2010